John Muir Physician Network Clinical Research Center

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Type 2 diabetes4 trials
• Obesity2 trials
• Type 1 diabetes2 trials
• Familial hypercholesterolaemia1 trial
• High blood pressure1 trial

Phase

• Phase 35 trials
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Completed2 trials
• Recruiting1 trial
• Suspended1 trial

Lead sponsor

• Boehringer Ingelheim2 trials
• Carmot Therapeutics, Inc.1 trial
• Eli Lilly and Company1 trial
• Novartis Pharmaceuticals1 trial
• vTv Therapeutics1 trial

Running trials

• Recruiting

  EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  NCT07064473· Phase 3· Boehringer Ingelheim· Source

  Contact: Boehringer Ingelheim

• Active, not recruiting

  Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes

  NCT06334133· Phase 3· vTv Therapeutics· Source

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• High blood pressure1 recruiting
• Type 2 diabetes1 recruiting

Closed trials

• Completed

  A Study of CT-868 in Type 1 Diabetes Mellitus

  NCT06062069· Phase 2· Carmot Therapeutics, Inc.· Source

• Completed

  A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight

  NCT04184622· Phase 3· Eli Lilly and Company· Source